PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma

Abnormal proline-rich protein 11 (PRR11) expression is associated with various tumors. However, there are few reports concerning PRR11 with prognostic risk, immune infiltration, or immunotherapy of bladder urothelial carcinoma (BLCA). This study is based on online databases, such as Oncomine, GEPIA,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Wenpeng, Yi, Lijuan, Dong, Xiaoru, Cao, Mengjie, Zheng, Jinjuan, Wei, Qingling, Yuan, Chunlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899238/
https://www.ncbi.nlm.nih.gov/pubmed/36739300
http://dx.doi.org/10.1038/s41598-023-29316-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899238/
https://www.ncbi.nlm.nih.gov/pubmed/36739300
http://dx.doi.org/10.1038/s41598-023-29316-2

Ejemplares similares